Deadline: July 15, 2020
Applications for the Maryland Stem Cell Research Fund (MSCRF) Commercialization Program 2020 are now open. The MSCRF Commercialization Program was created to foster the transition of promising technologies having significant commercial potential from Universities, where they were discovered, to the commercial sector, where they can be developed into products and services that meet identified market needs.
Specifically, it is the intent of the Commercialization Program to foster the commercialization of such technologies through technology validation, market assessment, and the creation of University start-up companies in Maryland. A “University Start-up” is a company reliant on a technology licensed from a University for commencement of its operations.
Award
- Subject to meeting the program requirements, awards of up to $270,000, may be made directly to a startup company.
Eligibility
Applicants for Commercialization Program must be a Start-up meeting the following criteria in order to be eligible for funding from the Program:
- The new start-up has licensed technology from a University or a research institute within twelve (12) months of applying for a Program award; if the technology has not yet been licensed, a fully executed license agreement will be required within 90 days of notification of the MSCRF award. (A copy of the license agreement will be required to receive any funds).
- An established company working on a new product or new technology that they developed or licensed in.
- The company must be located in Maryland.
Application
Applications must include all of the following sections:
- Header/Applicant Information (Cover page)
- Technology Description, Status, and Intellectual Property
- Application of Technology as a Product/Market Assessment
- Commercialization Pathway and Risk Assessment
- Project Description, Milestones, and Detailed Budget/Justification
- Executive Summary
For more information, visit MSCRF Commercialization Program.
